Aug 13 |
Avon owner files for bankruptcy after wave of talc cancer claims
|
Aug 13 |
3 Blue-Chip Stocks to Buy on the Dip: August 2024
|
Aug 13 |
Johnson & Johnson (NYSE:JNJ) is favoured by institutional owners who hold 71% of the company
|
Aug 13 |
Johnson & Johnson’s new robotic surgical system to rival Intuitive Surgical’s da Vinci
|
Aug 12 |
J&J makes headway in settling talc baby powder litigation: reports
|
Aug 12 |
Update: Market Chatter: Johnson & Johnson Clears Key Hurdle to Resolve Baby Powder Lawsuits
|
Aug 12 |
J&J has enough support from claimants for $6.5-billion talc settlement, Bloomberg reports
|
Aug 12 |
FDA Rejection of MDMA Therapy Isn’t End of Psychedelic-Drug Candidates
|
Aug 12 |
Medicare Costs For Johnson & Johnson's Psoriasis Drug Stelara Double When Obtained at Pharmacies
|
Aug 12 |
Big Drugmakers Are Clinching Smaller Deals
|